At the news
? NEUTRALIMPACT 2/10 144 filed May 13, 2026 at 15:13 ET
Gaurav Shah, an officer and director of Rocket Pharmaceuticals, filed a Form 144 notice of intent to sell 2,728 shares of common stock, with an approximate market value of $9,836. The shares were acquired on May 11, 2026, through restricted stock vesting as compensation. This is a routine, small-dollar sale by an insider to cover tax obligations from equity vesting, with no material impact on the company's outlook.
- Insider Gaurav Shah (Officer and Director) filed Form 144 to sell 2,728 shares
- Estimated sale value: $9,836.08
- Shares acquired on May 11, 2026 via restricted stock vesting (compensation)
- Sale is to cover tax obligations from vested equity award distribution
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access